Potential genetic markers of sporadic Alzheimer's dementia

Psychiatric Genetics

Volumn 11, Issue 3, 2001, Pages 115-122

  Retz, W ^a   Thome, J ^b   Durany, N ^c   Harsanyi A ^c   Retz Junginger, P ^a   Kornhuber, J ^c,d   Riederer, P ^c   Rosler M ^a  

^a SAARLAND UNIVERSITY   (Germany)

^b CENTRAL INSTITUTE OF MENTAL HEALTH   (Germany)

^c UNIVERSITY OF WÜRZBURG   (Germany)

^d UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

1 antichymotrypsin; Alzheimer's disease; Apolipoprotein CI; Apolipoprotein E; Genetics; Lipoprotein lipase; Low density lipoprotein receptor; Polymorphism

Indexed keywords

ALANINE; ALPHA 1 ANTICHYMOTRYPSIN; APOLIPOPROTEIN C1; APOLIPOPROTEIN E; LIPOPROTEIN LIPASE; LOW DENSITY LIPOPROTEIN RECEPTOR; THREONINE;

AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; EXON; FEMALE; GENETIC LINKAGE; GENETIC MARKER; GENETIC POLYMORPHISM; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR;

AGED; ALPHA 1-ANTICHYMOTRYPSIN; ALZHEIMER DISEASE; APOLIPOPROTEIN C-I; APOLIPOPROTEINS C; APOLIPOPROTEINS E; DNA PRIMERS; EXONS; FEMALE; GENETIC MARKERS; GENOTYPE; HUMANS; INTRONS; LIPOPROTEIN LIPASE; MALE; RECEPTORS, LDL; REFERENCE VALUES;

EID: 0034776045     PISSN: 09558829     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041444-200109000-00002     Document Type: Article

References (57)

1. 1-antichymotrypsin in the brain amyloid deposits of Alzheimer's disease
2. Role of common genetic polymorphism in the LDL receptor gene in affecting plasma cholesterol levels in the general population
3. The polymorphism in exon 3 of the low density lipoprotein receptor-related protein gene is weakly associated with Alzheimer's disease
4. A polymorphism in the regulatory region of APOE associated with risk for Alzheimer's dementia
5. Polygenic determinants of Alzheimer's disease: Modulation of the risk by alpha-1-antichymotrypsin
6. Relationship between the alpha1-antichymotrypsin microsatellite polymorphism and apolipoprotein-E in Alzheimer's disease
7. 1-antichymotrypsin and apolipoprotein E in Alzheimer's disease and vascular dementia
8. Phosphoethanolamine and ethanolamine are decreased in Alzheimer's disease and Huntington's disease
9. 1-antichymotrypsin deficiency in a heterozygote with liver and lung disease
10. No risk between the APOE and the alpha-1-antichymotrypsin genes on risk for Alzheimer's disease
11. 1-Antichymotrypsin binding to Alzheimer Aβ peptides is sequence specific and induces fibril disaggregation in vitro
12. Detection of three separate DNA polymorphisms in the human lipoprotein lipase gene by gene amplification and restriction endonuclease digestion
13. Effect of the StuI polymorphism in the LDL receptor gene (Ala 370 to Thr) on lipid levels in healthy individuals
14. No genetic effect of alpha 1-antichymotrypsin in Alzheimer's disease
15. Apolipoprotein E and cholesterol affect neuronal calcium signalling: The possible relationship to beta-amyloid neurotoxicity
16. The very low density lipoprotein (VLDL) receptor is a genetic susceptibility factor for Alzheimer disease in a European Caucasian population
17. No association between alphal-antichymotrypsin polymorphism, apolipoprotein E and patients with late-onset Alzheimer's disease
18. Confirmation of an association between a polymorphism in exon 3 of the low-density lipoprotein receptor-related protein gene and Alzheimer's disease
19. 1-antichymotrypsin polymorphism
20. Genetic association study between senile dementia of Alzheimer's type and APOE/C1/C2 gene cluster
21. Genetic association of the low-density lipoprotein receptor-related protein gene (LRP), an apolipoprotein E receptor, with late-onset Alzheimer's disease
22. Diagnostic accuracy of Alzheimer's disease: A neuropathological study
23. LDL receptor-related protein, a multifunctional ApoE receptor, binds secreted beta-amyloid precursor protein and mediates its degradation
24. Two copies of the human apolipoprotein C-I gene are linked closely to the apolipoprotein E gene
25. 1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer β-protein into filaments
26. Apolipoprotein E: Cholesterol transport protein with expanding role in cell biology
27. Alpha 1-antichymotrypsin as a possible biochemical marker for Alzheimer-type dementia
28. Increased 3-nitrotyrosine in brains of Apo E-deficient mice
29. Risk of Alzheimer's disease is associated with a very low-density lipoprotein receptor genotype in Northern Ireland
30. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services task force on Alzheimer's disease
31. Central nervous system lipoproteins in Alzheimer's disease
32. Lack of association between alpha 1-antichymotrypsin polymorphism, Alzheimer's disease, and allele epsilon 4 of apolipoproteine E
33. No association between the alpha 1-antichymotrypsin A allele and Alzheimer's disease
34. Apolipoprotein E and alpha-1-antichymotrypsin polymorphism in Alzheimer's disease
35. Human ApoCI HpaI restriction site polymorphism revealed by the polymerase chain reaction
36. Evidence for membrane defect in Alzheimer disease brain
37. Genetic association of the very low density lipoprotein (VLDL) receptor gene with sporadic Alzheimer's disease
38. Association between lipoprotein lipase gene polymorphisms and plasma correlations of lipids, lipoproteins and lipase activities in young myocardial infarction survivors and age-matched healthy individuals from Sweden
39. A closely linked gene to apolipoprotein E may serve as an additional risk factor for Alzheimer's disease
40. Unity in function in the absence of consequence in sequence: Role of leader peptides in export
41. 2-macroglobulin receptor/low-density-lipoprotein receptor-related protein
42. Pathologic verification of ischemic score in differentiation of dementias
43. Membrane alterations as causes of impaired signal transduction in Alzheimer's disease and aging
44. Apolipoprotein E: A review of its roles in lipoprotein metabolism, neuronal growth and repair and as a risk factor for Alzheimer's disease
45. Association of apolipoprotein E allele 4 with late-onset familial and sporadic Alzheimer's disease
46. Apolipoprotein E: High avidity binding to β-amyloid and increased frequency of type 4 allele in late onset familial Alzheimer disease
47. Polymorphism in AACT gene may lower age of onset of Alzheimer's disease
48. Alpha-1-antichymotrypsin bi-allele polymorphism, apolipoprotein-E tri-allele polymorphism and genetic risk of Alzheimer's syndrome
49. Polymorphisms of the human apolipoprotein E promoter and bleomycin hydrolase gene: Risk factors for Alzheimer's dementia?
50. 1-antichymotrypsin, presenilin-1, angiotensin-converting enzyme, and methylentetrahydrofolat reductase loci as candidates for dementia
51. Cerebral lipid deposition in aged apolipoprotein-E-deficient mice
52. Human apolipoprotein E: The Alzheimer's disease connection
53. Apolipoprotein C-I modulates the interaction of apolipoprotein E with β-migrating very low density lipoproteins (β-VLDL) and inhibits binding of β-VLDL to low density lipoprotein receptor-related protein
54. Acceleration of Alzheimer's fibril formation by apolipoprotein E in vitro
55. Alphal-antichymotrypsin as a risk modifier for late-onset Alzheimer's disease in Japanese apolipoprotein E epsilon 4 carriers